Buctolan, Baby Boy .
HRN: 24-45-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
01/26/2024
02/01/2024
IV
24mg As LD Then 12mg
Q24
Prematurity
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes